Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

innovaTIL-04, Study of LN-145, Autologous Tumor Infiltrating Lymphocytes in the Treatment of Patients With Cervical Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03108495
Recruitment Status : Recruiting
First Posted : April 11, 2017
Last Update Posted : April 18, 2019
Sponsor:
Information provided by (Responsible Party):
Iovance Biotherapeutics, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : March 2020
  Estimated Study Completion Date : September 2024